Impact BioMedical Inc. to Present at The Microcap Conference
Impact BioMedical Inc. (NYSE American: IBO) has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Impact BioMedical Inc. (NYSE American: IBO) has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. CEO Frank D. Heuszel will deliver a corporate presentation on Wednesday, January 29, 2025, at 10:30 AM ET.
During the conference, Heuszel will conduct one-on-one meetings with investors to discuss the company's recent developments, growth strategy, and investment opportunities. Impact BioMedical, a biotechnology company, focuses on discovering, confirming, and patenting unique science and technologies for development into biopharmaceuticals and consumer healthcare solutions through various collaborative relationships including research, licensing, co-development, and joint ventures.
Details
News Market Reaction – IBO
The recorded move for IBO in the trading session of this news was +12.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that Frank D. Heuszel, Chief Executive Officer, is pleased to announce his participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Mr. Heuszel will deliver a corporate presentation and engage in one-on-one meetings with investors to discuss the company’s recent developments, growth strategy, and investment opportunities. Details regarding his presentation are below.
Impact BioMedical Inc. Microcap Conference Presentation
Date: Wednesday, January 29, 2025
Time: 10:30 AM ET
About Impact BioMedical, Inc.:
Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships.
Investor Relations:
info@impactbiomedinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.